Uterine fibroids are the most common solid tumors of female genital tract ;they develop in 20%–40% of women of childbearing age [1] . The true prevalence of uterine fibroids is unknown, because more than 50% of these tumors are asymptomatic [2] .
Twenty percent to 30% of hysterectomies are performed to treat uterine fibroids that cause bleeding, pelvic pain, and/or refractory anemia [3] .However, therapeutic alternatives to hysterectomy exist for patients with these neoplasms. A primary
alternative is treatment with gonadotropin-releasing hormone agonists, alone or in combination with more conservative surgical treatments, such as myomectomy or myolysis. Gonadotropin-releasing hormone agonists have not been proven to be a definitive solution [4] . Uterine artery embolization (UAE) was introduced in 1995 [5].since that time it has been described as an alternative to hysterectomy for the management of non-acute uterine hemorrhage caused by fibroids [6]0 . The aim of our
study is to evaluate the efficiency of uterine artery embolization in treatment of symptomatic uterine fibroids.